Differential knockdown of δ-opioid receptor subtypes in the rat brain by antisense oligodeoxynucleotides targeting mRNA

Antisense and Nucleic Acid Drug Development

Volumn 9, Issue 2, 1999, Pages 203-211

  Negri, Lucia ^a   Lattanzi, Roberta ^a   Borsodi, Anna ^b   Toth, Geza ^b   Salvadori, Severo ^c  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^c UNIVERSITY OF FERRARA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; BRAIN RECEPTOR; DELTA OPIATE RECEPTOR; DELTORPHIN; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; MESSENGER RNA; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; NALTRINDOLE; OPIATE AGONIST; OPIATE ANTAGONIST; RECEPTOR SUBTYPE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING KINETICS; BRAIN; BRAIN MEMBRANE; CONTROLLED STUDY; IMMUNOBLOTTING; LATERAL BRAIN VENTRICLE; LOCOMOTION; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; RECEPTOR DENSITY;

ANIMALIA; RATTUS NORVEGICUS;

EID: 0033066793     PISSN: 10872906     EISSN: None     Source Type: Journal    
DOI: 10.1089/oli.1.1999.9.203     Document Type: Article

References (8)

1. ABDELHAMID, E.E., SULTANA, M., PORTHOGHESE, P.S., and TAKEMORI, A.E. (1991). Selective blockage of δ opioid receptor prevents the development of morphine tolerance and dependence in mice. J. Pharmacol. Exp. Ther. 258, 299-303.
2. ABOOD, M.E., NOEL, M.A., FARNSWORTH, J.S., and TAO, Q. (1994). Molecular cloning and expression of a δ-opioid receptor from rat brain. J. Neurosci. Res. 37, 714-719.
3. ADAMS, J.U., TALLARIDA, R.J., GELLER, E.B., and ADLER, M.W. (1993). Isobolographic superadditivity between delta and mu opioid agonists in the rat depends on the ratio of compounds, the mu agonist and the analgesic assay used. J. Pharmacol. Exp. Ther. 266, 1261-1267.
4. BILSKY, E.J., BERNSTEIN, R.N., HRUBY, V.J., ROTHMAN, R.B., LAI, J., and PORRECA, F. (1996). Characterization of antinociception to opioid receptor selective agonists after antisense oligodeoxynucleotide-mediated "knock-down" of opioid receotors in vivo. J. Pharmacol. Exp. Ther. 277, 491-501.
5. 2]deltorphin II, in the rat. Eur. J. Pharmacol. 218, 69-73.
6. BROCCARDO, M., IMPROTA, G., and TABACCO, A. (1998). Central effect of SNC80, a selective and systemically active delta-opioid receptor agonist, on gastrointestinal propulsion in the mouse. Eur. J. Pharmacol. 342, 247-251.
7. VU, A., and HIRSCHBEIN, B.L. (1991). Internucleotide phosphite sulfurization with tetraethylthiuram disulfide phosphorothioate oligonucleotide synthesis via phosphoramidite chemistry. Tetrahedron Lett. 32, 3005-3008.
8. WANG, H.Q., KAMPINE, J.P., and TSENG, L.F. (1996). Antisense oligodeoxynucleotide to a δ-opioid receptor messenger RNA selectively blocks the antinociception induced by intracerebroventricularly administered δ- but not μ-, ε- or κ-opioid receptor agonists in the mouse. Neuroscience 75, 445-452.